Clinical impact of introduction of mammography screening in a non-screening country: With special reference to the copenhagen service mammography screening programme

Scandinavian Journal of Surgery

Volumn 91, Issue 3, 2002, Pages 293-303

  Tange, Ulla Brix ^a   Jensen, M B ^a   Vejborg, I M M ^a   Rank, F E ^a   Blichert Toft, M ^a   Mouridsen, H T ^a   Lynge, E ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Breast cancer; Clinical findings; Clinical stage; Imaging methods; Mammography screening; Population acceptability; Surrogate indicators treatment

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; EUROPE; HUMAN; MAMMOGRAPHY; PRACTICE GUIDELINE; REVIEW;

EID: 0036409377     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690209100314     Document Type: Review

References (50)

1. Perry N, Broeders M, de Wol C, Törnberg S: European guidelines for quality assurance in mammography screening. European Commission. Luxembourg, 2001;1-367
2. Duffy SW, Tabar L, Fagerberg G, Gad A, Grontoft O, South MC, Day NE: Breast screening, prognostic factors and survival - Results from the Swedish two-county study. Br J Cancer 1991;64:1133-1138
3. Smart CR, Byrne C, Smith RA, Garfinkel L, Letton AH, Dodd GD, Beahrs OH: Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47:134-149
4. Miller BA, Feuer EJ, Hankey BF: Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J Clin 1993;43:27-41
5. Day NE, Williams DRR, Khaw KT: Breast cancer screening programmes: The development of a monitoring and evaluation system. Br J Cancer 1989;59:954-958
6. Moody C, Corder A, Mullee MA, Guyer P, Rubin C, Cross M, Royle GT, Taylor I: The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer. J R Soc Med 1994;87:259-262
7. Rickard M: Diagnosis of small sized invasive breast cancer by an Australian mammography screening service: Surrogate end-points for mortality reduction. Aust N Z J Surg 1998;68:415-8
8. Kerlikowske K: Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997;79-86
9. Rostgaard K, Holst H, Mouridsen HT, Lynge E: Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 2000;11:669-674
10. Copenhagen Mammography Screening Evaluation Group: Mammography screening for breast cancer in Copenhagen April 1991-March 1997. APMIS 1998;106:1-44
11. Fracheboud J: Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990- 1995. National evaluation team for breast cancer screening. Int J Cancer 1998;75:694-8
12. Moss SM: Results from the NHS breast screening programme 1990-1993. J Med Screen 1995;2:186-90
13. Paci E: Early indicators of efficacy of breast cancer screening programmes. Results of the Florence district programme. Int J Cancer 1990;46:198-202.
14. Doyle TC: Clinical outcomes of the Otago-Southland breast cancer screening programme 1991-1996. N Z Med J 1998;111:380-3
15. Jørgensen T: Mammografiscreening i københavns kommune. Ugeskr Læger 1996;158:1212-1216
16. Hirsch FR: Behandling af primær cancer mammae. Ugeskr Læger 1996;158:1218-1221
17. Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H, Lynge E: Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds. Ugeskr Laeger 2002;164:1036-1040
18. Tabar L: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210
19. Miller AB, Baines CJ, To T, Wall C: Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477-1488
20. Autier P, Shannoun F, Scharpantgen A, Lux C, Back C, Severi G, Steil S, Hansen-Koenig D: A breast cancer screening programme operating in a liberal health care system: The Luxembourg Mammography Programme, 1992-1997. Int J Cancer 2002;97:828-832
21. Tabar L: Reduction in mortality from breast cancer after mass screening with mammography. randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32
22. Tabar L, Duffy SW, Krusemo UB: Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol 1987;23:959-962
23. Pamilo M, Anttinen I, Roiha M, Kallio H, Tallqvist G, Soiva M, Paloheimo J, Kiviluoto H, Suramo I: Mammography screening for breast cancer: First year results from Helsinki and surroundings. Ann Med 1989;21:277-279
24. Tabar L: Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results. Swiss Surg 1999;5:199-204
25. Ernst MF, Voogd AC, Coebergh JW, Repelaer van Driel OJ, Roukema JA: The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer 2001;37:2435-2440
26. Farwell MF, Foster RS Jr, Costanza MC: Breast cancer and earlier detection efforts. Realized and unrealized impact on stage. Arch Surg 1993;128:510-513
27. Jamrozik K, Byrne MJ, Dewar JM, Harvey JM, Ingram DM, Parsons RW, Watson N: The effect of mammographic screening on invasive breast cancer in Western Australia. Med J Aust 2000;172:203-206
28. Olivotto IA, Mates D, Kan L, Fung J, Samant R, Burhenne LJ: Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Res Treat 1999;54:73-81
29. Borras JM, Espinas JA, Beemsterboer PM, Granados A, de Koning HJ: Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making. Int J Technol Assess Health Care 1998;14:268-276
30. de Koning HJ: Breast cancer screening: Its impact on clinical medicine. Br J Cancer 1990;61:292-7
31. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-918
32. de Koning HJ, van Dongen JA, van der Maas PJ: Changes in use of breast-conserving therapy in years 1978-2000. Br J Cancer 1994;70:1165-1170
33. Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H, Lynge E: [Mammography screening in the county of Copenhagen. Results of the first three screening rounds]. Ugeskr Laeger 2002;164:1048-1052
34. Ekeberg O, Skjauff H, Kåresen R: Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001;10:20-24
35. von Bulow B: Psychological reactions connected to screening participation - Illustrated by breast cancer screening. Ugeskr Laeger 2002;164:165-167
36. von Bulow B: [Psychological consequences of breast cancer screening among healthy women]. Ugeskr Laeger 2000;162:1053-1059
37. Burman ML, Taplin SH, Herta DF, Elmore JG: Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1-6
38. Boer R, Warmerdam PG, de Koning HJ, van Oortmarssen GJ: Extra incidence caused by mammographic screening. Lancet 1994;343:979-979
39. Chu KC, Smart CR, Tarone RE: Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988;80:1125-1132
40. Tabar L: Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med 1985;54:158-64.
41. Fagerberg G, Baldetorp L, Grontoft O, Lundstrom B, Manson JC, Nordenskjold B: Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county. Acta Radiol Oncol 1985;24:465-473
42. Andersson I: Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial. BMJ 1988;297:943-8.
43. Frisell J, Glas U, Hellstrom L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 1986;8:45-54
44. Roberts MM: Edinburgh trial of screening for breast cancer: Mortality at seven years. Lancet 1990;335:241-6
45. Miller AB, Baines CJ, To T, Wall C: Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992;147:1459-1476
46. Shapiro S: Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39:2772-2782
47. Collette C, Collette HJ, Fracheboud J, Slotboom BJ, de Waard F: Evaluation of a breast cancer screening programme - The DOM project. Eur J Cancer 1992;28A:1985-1988
48. Hakama M: Aggressiveness of screen-detected breast cancers. Lancet 1995;345:221-4.
49. Peer PG: Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: Assessment of early indicators of screening effectiveness. J Natl Cancer Inst 1994;86:436-41.
50. DBCG: DBCG - Danish Breast Cancer Cooperative Group. Reprint. Copenhagen, 1997